CONMED Corp — Director's Dealing 2015

Nov 25, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2015-11-23

Reporting Person: Snyder Mark D (EVP Mfg. Ops & Business System)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-11-23	Common Stock	M	8000	$27.63	Acquired	19249	Direct
2015-11-23	Common Stock	F	5955	$42.36	Disposed	13294	Direct
2015-11-23	Common Stock	M	2000	$26.09	Acquired	15294	Direct
2015-11-23	Common Stock	F	1436	$42.36	Disposed	13858	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-11-23	Sars (Stock Appreciation Rights)	$27.63	M	8000	Disposed	2021-06-01	Common Stock (8000)	Direct
2015-11-23	Sars (Stock Appreciation Rights)	$26.09	M	2000	Disposed	2022-06-01	Common Stock (2000)	Direct

Footnotes

F1: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.